Please login to the form below

Not currently logged in
Email:
Password:

PureTech appoints Joseph Bolen as entrepreneur-in-residence

And Vincent Hennemand joins as VP, company development and operations

PureTech Health Joseph BolenBoston-based PureTech Health has appointed Joseph Bolen (pictured) as entrepreneur-in-residence.

He previously served as president of research and development at Moderna Therapeutics and as chief scientific officer at Millennium Pharmaceuticals.

Prior to joining Millennium in 1999, Dr. Bolen held senior R&D positions at Hoechst Marion Roussel, Schering-Plough, and Bristol-Myers Squibb.

As PureTech's entrepreneur-in-residence he will work with the firm's company creation team to identify and pursue promising new medicines.

Also joining PureTech, which focuses on developing novel medicines, is Vincent Hennemand.

He was formerly principal in Sanofi's corporate R&D venture group and joins the cross-disciplinary healthcare firm as its vice president of company development and operations.

Prior to that Hennemand was chief of staff to the president of global R&D and the general secretary for the corporate scientific advisory committee (SDSAC), which investigates scientific proposals and projects of potential interest to Sanofi.

9th December 2015

From: Research

Share

Tags

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Streaming Well

Streaming Well is a healthcare-focused, award-winning video production company which operates in the US and Europe. We create engaging visual...

Latest intelligence

What challenges still face clinical trial recruitment and retention?
Discover the reasons for the current clinical trial recruitment challenges facing pharma and the life sciences industry, and how the search for solutions to the problem continues...
“Fake News” and Credibility in Medical Publishing
Natalie Yeadon from Impetus Digital shares her thoughts on fighting fake news in Pharma and healthcare....
Delivering true value: what does it mean for KAM in cancer care?
Lisa Alderson, Business Development Director at Wilmington Healthcare, explores the challenges that pharma’s KAM teams face in engaging with the NHS and how they must evolve...

Infographics